OptimizeRx AI driven Healthtech aims to smooth the treatment path for patients. CONTEXT: Only in America do you need this type of tech (not entirely true but in the civilised Continue Reading
Large scale multiple sclerosis registry launches. CONTEXT: Announcement of The OM1 MS registry is a continually updating database of more than 20,000 patientsprospectively followed with deep clinical, laboratory and other data, such as longitudinal Continue Reading
Real-world evidence in advertising CONTEXT: A very interesting opinion piece on the implications of the increased role of real-world evidence (RWE) in the pharmaceutical industry. The article lays out the Continue Reading
NESTcc adds laboratory and patient engagement experts to Governing Committee CONTEXT: The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), Continue Reading
750,000 deaths in India linked to abnormal hot and cold temperatures CONTEXT: The numbers connected to climate change are almost as staggering as our ability to do so little about Continue Reading
Video presentation of real-world research on the impact of upfront chemo choice on second-line immunotherapy in bladder cancer. CONTEXT: Lead author Benjamin Miron presents findings of a real-world study into Continue Reading
Presentations at the European Crohn’s and Colitis Organization annual meeting supported the transition to adalimumab biosimilars and provided patient acceptance data. CONTEXT: Among the poster presentations described in this article Continue Reading
Implications of the upcoming changes to French ATU (Autorisation Temporaire d’Utilisation) programme CONTEXT: From July of 2021manufacturers will be required to make all early access authorisation requests to the HAS Continue Reading
Literature review demonstrates antifibrotic treatment reduces mortality and acute exacerbations in idiopathic pulmonary fibrosis patients. CONTEXT: A comprehensive literature review of antifibrotic treatment in idiopathic pulmonary fibrosis patients published in Continue Reading
Liquid biopsies can match non-small cell lung cancer (NSCLC) patients to life-prolonging targeted therapy CONTEXT: Liquid biopsies can match non-small cell lung cancer (NSCLC) patients to life-prolonging targeted therapy and Continue Reading
